INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 138 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $6,361,000 | +110.6% | 1,969,225 | +1.7% | 0.24% | +75.0% |
| Q3 2016 | $3,020,000 | +17.3% | 1,935,942 | 0.0% | 0.14% | +38.6% |
| Q2 2016 | $2,575,000 | -88.9% | 1,935,942 | -56.0% | 0.10% | -89.8% |
| Q1 2016 | $23,182,000 | -31.4% | 4,398,862 | +2.2% | 0.99% | -28.0% |
| Q4 2015 | $33,797,000 | +2.3% | 4,305,288 | +10.1% | 1.37% | +7.2% |
| Q3 2015 | $33,046,000 | +22.4% | 3,910,721 | +58.6% | 1.28% | +42.2% |
| Q2 2015 | $26,993,000 | -51.3% | 2,465,129 | -37.9% | 0.90% | -50.0% |
| Q1 2015 | $55,475,000 | -14.9% | 3,968,155 | +2.9% | 1.80% | -23.2% |
| Q4 2014 | $65,158,000 | +25.0% | 3,857,805 | -0.6% | 2.34% | +23.3% |
| Q3 2014 | $52,107,000 | +11.3% | 3,882,805 | +5.7% | 1.90% | +0.8% |
| Q2 2014 | $46,817,000 | -11.4% | 3,674,838 | -17.3% | 1.88% | -12.7% |
| Q1 2014 | $52,839,000 | -8.5% | 4,444,027 | +6.3% | 2.16% | -27.9% |
| Q4 2013 | $57,750,000 | +52.6% | 4,181,743 | +92.6% | 2.99% | +69.9% |
| Q3 2013 | $37,853,000 | -0.7% | 2,171,744 | -7.8% | 1.76% | -2.0% |
| Q2 2013 | $38,132,000 | – | 2,354,963 | – | 1.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,354,963 | $38,132,000 | 1.80% |
| Orbimed Advisors | 4,520,800 | $73,201,000 | 1.55% |
| QVT Financial LP | 1,326,610 | $21,480,000 | 1.44% |
| BB BIOTECH AG | 1,089,828 | $17,646,000 | 1.27% |
| Meditor Group Ltd | 250,000 | $4,048,000 | 0.55% |
| Perimeter Capital Partners, LLC | 159,915 | $2,589,000 | 0.50% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 156,808 | $2,539,000 | 0.43% |
| Broadfin Capital, LLC | 117,172 | $1,897,000 | 0.37% |
| OXFORD ASSET MANAGEMENT LLP | 811,331 | $13,184,000 | 0.36% |
| Baker Brothers Advisors | 1,016,433 | $16,458,000 | 0.33% |